Hrishikesh Srinagesh

7PUBLICATIONS
71CO-AUTHORS
Preventative health careReaction engineering (excl. nuclear reactions)Haematological tumoursAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 16, 2026
A QUEST to improve outcomes for adults with high-risk B-ALL.

|Apr 02, 2026
Zamtocabtagene autoleucel: dual CD20-CD19 targeting for NHL.

Hrishikesh K Srinagesh, Lori S Muffly

|Feb 05, 2026
Blinatumomab nonresponse correlates with poor survival after brexucabtagene autoleucel in B-cell ALL.

Hrishikesh Krishna Srinagesh, Vishal K Gupta, Amy Zhang

|Dec 18, 2025
Clinical and Cytokine Features of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome.

Hrishikesh K Srinagesh, Anne Marijn Kramer, John H Baird

|Jan 08, 2025
Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCL.

Yi-Jiun Su, Anne Marijn Kramer, Mark P Hamilton

|Jul 05, 2024
A phase 1 clinical trial of NKTR-255 with CD19-22 CAR T-cell therapy for refractory B-cell acute lymphoblastic leukemia.

Hrishikesh Srinagesh, Clayton Jackson, Parveen Shiraz

Pageof 2

Frequent Collaborators

6 joint publications

Lori S Muffly

3 joint publications

Anne Marijn Kramer

3 joint publications

Steven Feldman

3 joint publications

Crystal Mackall